Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab

被引:17
作者
El-Shanawany, T. M. [1 ]
Williams, P. E. [1 ]
Jolles, S. [1 ]
机构
[1] Univ Hosp Wales, Dept Immunol, Cardiff CF14 4XW, Wales
关键词
D O I
10.1136/jcp.2006.041426
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:715 / 716
页数:2
相关论文
共 13 条
[1]   Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency [J].
Carbone, J ;
Escudero, A ;
Mayayo, M ;
Ballesteros, M ;
Perez-Corral, A ;
Sanchez-Ramon, S ;
Sarmiento, E ;
Micheloud, D ;
Fernandez-Cruz, E .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :666-671
[2]   Delayed-onset neutropenia associated with rituximab therapy [J].
Chaiwatanatorn, K ;
Lee, N ;
Grigg, A ;
Filshie, R ;
Firkin, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (06) :913-918
[3]   Diagnostic criteria for primary immunodeficiencies [J].
Conley, ME ;
Notarangelo, LD ;
Etzioni, A .
CLINICAL IMMUNOLOGY, 1999, 93 (03) :190-197
[4]   The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura [J].
Cooper, N ;
Stasi, R ;
Cunningham-Rundles, SS ;
Feuerstein, MA ;
Leonard, JP ;
Amadori, S ;
Bussel, JB .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) :232-239
[5]   Common variable immunodeficiency: Clinical and immunological features of 248 patients [J].
Cunningham-Rundles, C ;
Bodian, C .
CLINICAL IMMUNOLOGY, 1999, 92 (01) :34-48
[6]   Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia [J].
Faurschou, M ;
Hasselbach, HC ;
Nielsen, OJ .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (06) :408-411
[7]   Clinical uses of intravenous immunoglobulin [J].
Jolles, S ;
Sewell, WAC ;
Misbah, SA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (01) :1-11
[8]   Anti B cell therapy (rituximab) in the treatment of autoimmune diseases [J].
Kazkaz, H ;
Isenberg, D .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :398-402
[9]   Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses [J].
Kumar, S ;
Diehn, FE ;
Gertz, MA ;
Tefferi, A .
ANNALS OF HEMATOLOGY, 2002, 81 (06) :312-319
[10]  
Leget Gail A., 1998, Current Opinion in Oncology, V10, P548, DOI 10.1097/00001622-199811000-00012